Clinical Trials Browser

Completed × aumolertinib × 1 year × Clear all

NCT06613633 2026-04-29

Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Carcinoma, Non-Small-Cell Lung